X染色体遗传学与人类癌症。 - Suppr

Suppr

超能文献

X-chromosome genetics and human cancer.

作者信息

Spatz Alain, Borg Christophe, Feunteun Jean

机构信息

Institut Gustave-Roussy and UMR 8125 CNRS, 94805 Villejuif, France.

出版信息

Nat Rev Cancer. 2004 Aug;4(8):617-29. doi: 10.1038/nrc1413.

DOI:10.1038/nrc1413

PMID:15286741

Abstract

摘要

相似文献

X-chromosome genetics and human cancer.

Nat Rev Cancer. 2004 Aug;4(8):617-29. doi: 10.1038/nrc1413.

Epigenetic gene silencing in cancer.

J Clin Invest. 2000 Feb;105(4):401-7. doi: 10.1172/JCI9462.

[Oncogenes, oncoproteins and tumor suppressor genes. Significance in carcinogenesis].

Dtsch Med Wochenschr. 1991 Oct 11;116(41):1563-8. doi: 10.1055/s-2008-1063790.

Genomic imprinting and gene activation in cancer.

Nat Genet. 1993 Jun;4(2):110-3. doi: 10.1038/ng0693-110.

Gene body-specific methylation on the active X chromosome.

Science. 2007 Feb 23;315(5815):1141-3. doi: 10.1126/science.1136352.

Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.

Cancer Res. 2005 Feb 15;65(4):1164-73. doi: 10.1158/0008-5472.CAN-04-2688.

Genomic profiling of breast cancer.

J Surg Oncol. 2009 May 1;99(6):386-92. doi: 10.1002/jso.21249.

Reversibility of oncogene-induced cancer.

Curr Opin Genet Dev. 2004 Feb;14(1):37-42. doi: 10.1016/j.gde.2003.12.008.

Chromosomes, oncogenes, and neoplasia.

Del Med J. 1990 Sep;62(9):1227-30.

Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.

Cancer Res. 2006 Jun 1;66(11):5582-91. doi: 10.1158/0008-5472.CAN-05-3575.

引用本文的文献

The relative contributions of genetic and non-genetic factors to the risk of neuroblastoma.

Pediatr Investig. 2024 Oct 30;9(1):82-93. doi: 10.1002/ped4.12455. eCollection 2025 Mar.

Deletion of Xist repeat B disrupts cell cycle and asymmetric cell division through Usp9x hyperactivation in mice.

Nucleic Acids Res. 2025 Feb 27;53(5). doi: 10.1093/nar/gkaf142.

Defective X-chromosome inactivation and cancer risk in women.

Commun Biol. 2025 Feb 22;8(1):289. doi: 10.1038/s42003-025-07691-y.

Unravelling single-cell DNA replication timing dynamics using machine learning reveals heterogeneity in cancer progression.

Nat Commun. 2025 Feb 8;16(1):1472. doi: 10.1038/s41467-025-56783-0.

FHL1 as a prognostic biomarker and therapeutic target in acute promyelocytic leukaemia.

Discov Oncol. 2025 Jan 19;16(1):59. doi: 10.1007/s12672-025-01738-6.

Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the and Genes.

Biomedicines. 2024 Dec 20;12(12):2906. doi: 10.3390/biomedicines12122906.

TMSB4Y restrains sphingomyelin synthesis via de novo purine synthesis to exert a tumor suppressor function in male esophageal squamous cell carcinoma.

Oncogene. 2024 Dec;43(50):3660-3672. doi: 10.1038/s41388-024-03193-z. Epub 2024 Oct 23.

Genetic and Epigenetic Association of with Papillary Thyroid Cancer Predisposition.

Int J Mol Sci. 2024 Jun 28;25(13):7161. doi: 10.3390/ijms25137161.

Cancer risk in individuals with polydactyly: a Swedish population-based cohort study.

Br J Cancer. 2024 Sep;131(4):755-762. doi: 10.1038/s41416-024-02770-z. Epub 2024 Jun 29.

Oncogenes and tumor suppressor genes: functions and roles in cancers.

MedComm (2020). 2024 May 31;5(6):e582. doi: 10.1002/mco2.582. eCollection 2024 Jun.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验